| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1295 | 2022 |
| Outcomes of COVID-19 in patients with CLL: a multicenter international experience AR Mato, LE Roeker, N Lamanna, JN Allan, L Leslie, JM Pagel, K Patel, ... Blood, The Journal of the American Society of Hematology 136 (10), 1134-1143, 2020 | 305 | 2020 |
| Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study A Younes, J Brody, C Carpio, A Lopez-Guillermo, D Ben-Yehuda, ... The Lancet Haematology 6 (2), e67-e78, 2019 | 187 | 2019 |
| Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI C Montalbán, A Díaz‐López, I Dlouhy, J Rovira, A Lopez‐Guillermo, ... British Journal of Haematology 176 (6), 918-928, 2017 | 99 | 2017 |
| Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection L Prieto-Pérez, J Fortes, C Soto, Á Vidal-González, M Alonso-Riaño, ... Modern pathology 33 (11), 2139-2146, 2020 | 88 | 2020 |
| COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA L Pagano, J Salmanton-García, F Marchesi, A López-García, S Lamure, ... Blood, The Journal of the American Society of Hematology 139 (10), 1588-1592, 2022 | 83 | 2022 |
| Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research R Kanesvaran, R Cordoba, R Maggiore American Society of Clinical Oncology Educational Book 38, 400-414, 2018 | 81 | 2018 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 79 | 2021 |
| The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product R Cordoba, R Arrieta, A Kerguelen, F Hernandez-Navarro Bone marrow transplantation 40 (11), 1063-1067, 2007 | 68 | 2007 |
| Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study I Regalado-Artamendi, A Jiménez-Ubieto, JÁ Hernández-Rivas, ... Hemasphere 5 (3), e538, 2021 | 66 | 2021 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 65 | 2022 |
| COVID-19 in patients with CLL: improved survival outcomes and update on management strategies LE Roeker, TA Eyre, MC Thompson, N Lamanna, AR Coltoff, MS Davids, ... Blood, The Journal of the American Society of Hematology 138 (18), 1768-1773, 2021 | 60 | 2021 |
| Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier C Carpio, R Bouabdallah, L Ysebaert, JM Sancho, G Salles, R Cordoba, ... Blood, The Journal of the American Society of Hematology 135 (13), 996-1007, 2020 | 58 | 2020 |
| New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma … L Bento, A Díaz‐López, G Barranco, AM Martín‐Moreno, M Baile, A Martín, ... British journal of haematology 188 (6), 888-897, 2020 | 57 | 2020 |
| Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance T Jurado-Camino, R Cordoba, L Esteban-Burgos, E Hernández-Jiménez, ... The Journal of Immunology 194 (2), 719-727, 2015 | 53 | 2015 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 51 | 2022 |
| Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine TA Bennett, P Montesinos, F Moscardo, D Martinez-Cuadron, J Martinez, ... Clinical Lymphoma Myeloma and Leukemia 14 (4), 305-318, 2014 | 49 | 2014 |
| The spectrum of EBV-positive mucocutaneous ulcer: a study of 9 cases L Prieto-Torres, I Eraña, R Gil-Redondo, IG de la Riva, R Manso, ... The American Journal of Surgical Pathology 43 (2), 201-210, 2019 | 47 | 2019 |
| Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC) P Abrisqueta, J Delgado, M Alcoceba, AC Oliveira, J Loscertales, ... British journal of haematology 190 (6), 854-863, 2020 | 45 | 2020 |
| Cancer and aging in Ibero-America E Soto-Perez-de-Celis, R Cordoba, R Gironés, T Karnakis, I Paredero, ... Clinical and Translational Oncology 20, 1117-1126, 2018 | 42 | 2018 |
